Glaxo Says FDA Call About Zofran Suits Not 'Covert Lobbying'
By Kevin Stawicki · February 19, 2020, 3:58 PM EST
GlaxoSmithKline attorneys have told a Massachusetts federal judge that a 30-minute phone call with the U.S. Food and Drug Administration about multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login